Investors: Press Releases

Press Releases

September 10, 2021
NexImmune to Present at the Morgan Stanley 19th Annual Global Healthcare Conference
August 9, 2021
NexImmune Reports Second Quarter 2021 Financial Results and Provides Business Updates
August 9, 2021
NexImmune to Explore the Use of AIM™ Direct Injection Technology in Type 1 Diabetes
July 27, 2021
NexImmune to Announce Second Quarter 2021 Financial Results and Provide Corporate Update on August 9, 2021
July 14, 2021
NexImmune Strengthens Management Team with Key Appointments
June 16, 2021
NexImmune to Present at the Raymond James 2021 Human Health Innovation Conference
May 27, 2021
NexImmune Announces Formation of Scientific Advisory Board
May 19, 2021
NexImmune Announces Presentation of Preliminary Phase 1/2 Clinical Data at the 2021 American Society of Clinical Oncology Annual Meeting
May 17, 2021
NexImmune Reports First Quarter 2021 Financial Results and Recent Updates
April 21, 2021
NexImmune Appoints Chad Rubin as Senior Vice President, Corporate Affairs
Displaying 1 - 10 of 36